Keywords: Other Neurodegeneration, Relaxometry, Demyelination, remyelination, RAFF4, MT, DTI
Motivation: In vivo assessment of myelin status is important for diagnostic and therapeutic purposes in multiple sclerosis.
Goal(s): The goal of this study was to explore the capability of RAFF4, MT, and DTI metrics to detect changes in the myelin content and integrity during both demyelination and remyelination.
Approach: A genetic mouse model of widespread demyelination and remyelination was imaged with RAFF4, MT, and DTI and the MRI metrics were compared with histological analyses.
Results: Both RAFF4 and MT detected differences between the disease model and control animals in both demyelination and remyelination. DTI differed only in the demyelination phase.
Impact: RAFF4 showed the ability to detect both demyelination and remyelination in the mouse brain. This suggests that RAFF4 has great potential in serving as a translational biomarker in the development of new therapeutic agents for myelin repair.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords